Integrated Oncology Network PTY LTD

Brisbane, Queensland 4101

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer, Endometrial Cancer, Ovarian Cancer, Prostate Cancer, Solid Tumor

Studies at this site

• Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors. — Stopped early